HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Marked improvement of severe progressive systemic sclerosis after transplantation of mesenchymal stem cells from an allogeneic haploidentical-related donor mediated by ligation of CD137L.

AuthorsM Christopeit, M Schendel, J Föll, L P Müller, G Keysser, G Behre
JournalLeukemia (Leukemia) Vol. 22 Issue 5 Pg. 1062-4 (May 2008) ISSN: 1476-5551 [Electronic] England
PMID17972956 (Publication Type: Letter)
Chemical References
  • 4-1BB Ligand
  • Tumor Necrosis Factor Receptor Superfamily, Member 9
Topics
  • 4-1BB Ligand
  • Adult
  • Female
  • Humans
  • Immunophenotyping
  • Immunosuppression Therapy
  • Mesenchymal Stem Cell Transplantation
  • Scleroderma, Diffuse (therapy)
  • T-Lymphocytes (immunology)
  • Tissue Donors
  • Transplantation, Homologous
  • Tumor Necrosis Factor Receptor Superfamily, Member 9

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: